Skip to main content
Top
Published in: Urolithiasis 4/2006

01-08-2006 | Original Paper

Patients’ attitudes on how to deal with the risk of future stone recurrences

Author: Hans-Göran Tiselius

Published in: Urolithiasis | Issue 4/2006

Login to get access

Abstract

One hundred consecutive patients referred for active stone removal responded to a number of questions regarding their attitude to metabolic risk evaluation and recurrence prevention. Of the 74 men and 26 women all but one were interested in the cause of their disease. While 95% of the patients were motivated to change their dietary habits, only 71% were interested in pharmacological treatment. Collection of 24-h urine for risk evaluation in one or five fractions was acceptable to 94 and 84% of the patients, respectively. Only 79% wanted to collect urine during more than one 24-h period. Given the option of a recurrence prevention programme or active stone removal when or if a stone appeared, approximately half of our patients (52%) chose the first, and about one-third (29%) of them chose the second alternative, whereas as many as 19% of the patients did not express any opinion. A programme for regular follow-up in order to detect new stones early was appreciated by only 81 patients. These results show that biochemical risk evaluation and recurrence prevention is generally met with a positive attitude by most patients and that medical recurrence prevention appears to be appreciated by more than half of the patients.
Literature
1.
go back to reference Ahlstrand C, Tiselius HG (1990) Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 18:397–399PubMedCrossRef Ahlstrand C, Tiselius HG (1990) Recurrences during a 10-year follow-up after first renal stone episode. Urol Res 18:397–399PubMedCrossRef
2.
go back to reference Tiselius HG (2000) Stone incidence and prevention. Braz J Urol 26:453–462 Tiselius HG (2000) Stone incidence and prevention. Braz J Urol 26:453–462
3.
go back to reference Trinchieri A, Ostini F, Nespoli R, Revera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after first renal stone. J Urol 162:27–30PubMedCrossRef Trinchieri A, Ostini F, Nespoli R, Revera F, Montanari E, Zanetti G (1999) A prospective study of recurrence rate and risk factors for recurrence after first renal stone. J Urol 162:27–30PubMedCrossRef
4.
go back to reference Strohmaier WL (2004) Course of renal stone disease—an epidemiological view. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis. The Hong Kong Polytechnic University, Hong Kong (MDI Gohel), pp 377–385 Strohmaier WL (2004) Course of renal stone disease—an epidemiological view. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis. The Hong Kong Polytechnic University, Hong Kong (MDI Gohel), pp 377–385
5.
go back to reference Robertson WG, Peacock M, Nordin BEC (1968) Activity products in stone-forming and non-stone forming urine. Clin Sci 34:579–594 Robertson WG, Peacock M, Nordin BEC (1968) Activity products in stone-forming and non-stone forming urine. Clin Sci 34:579–594
6.
go back to reference Finlayson B (1974) Renal lithiasis in review. Urol Clin North Am 1:181–211PubMed Finlayson B (1974) Renal lithiasis in review. Urol Clin North Am 1:181–211PubMed
7.
go back to reference Nancollas GH (1976) The kinetics of crystal growth and renal stoneformation. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis research. Plenum, New York, pp 5–23 Nancollas GH (1976) The kinetics of crystal growth and renal stoneformation. In: Fleisch H, Robertson WG, Smith LH, Vahlensieck W (eds) Urolithiasis research. Plenum, New York, pp 5–23
8.
go back to reference Smith LH (1989) Medical aspects of urolithiasis: overview. J Urol 141:707–710PubMed Smith LH (1989) Medical aspects of urolithiasis: overview. J Urol 141:707–710PubMed
9.
go back to reference Baumann M (1990) Physico-chemical aspects of calcium stone formation. Urol Res 18:25–30CrossRef Baumann M (1990) Physico-chemical aspects of calcium stone formation. Urol Res 18:25–30CrossRef
10.
go back to reference Hess B, Tiselius HG (2002) Physical–chemical processes in kidney stone formation. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism (2 edn) Williams & Wilkins, Lippincott, pp 619–628 Hess B, Tiselius HG (2002) Physical–chemical processes in kidney stone formation. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism (2 edn) Williams & Wilkins, Lippincott, pp 619–628
11.
go back to reference Tiselius HG (2000) Comprehensive metabolic evaluation of stone formers is cost effective. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger G (eds) Urolithiasis 2000. Proceedings of the 9th international symposium on urolithiasis. University of Cape Town, Cape Town, pp 349–355 Tiselius HG (2000) Comprehensive metabolic evaluation of stone formers is cost effective. In: Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger G (eds) Urolithiasis 2000. Proceedings of the 9th international symposium on urolithiasis. University of Cape Town, Cape Town, pp 349–355
12.
go back to reference Tiselius HG (2004) Routine metabolic evaluation of patients with stone disease—aspects on its cost effectiveness. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis, The Hong Kong Polytechnic University, Hong Kong, (MDI Gohel), pp 372–376 Tiselius HG (2004) Routine metabolic evaluation of patients with stone disease—aspects on its cost effectiveness. In: Gohel MDI, Wt Au D (eds) Kidney stones: inside and out. Proceedings of the 10th international symposium on urolithiasis, The Hong Kong Polytechnic University, Hong Kong, (MDI Gohel), pp 372–376
13.
go back to reference Tiselius HG, Advisory Board of European Urolithiasis Research EAU Health Care Office Working Party for Urolithiasis (2001) Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 88:1–16 Tiselius HG, Advisory Board of European Urolithiasis Research EAU Health Care Office Working Party for Urolithiasis (2001) Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease. BJU Int 88:1–16
14.
go back to reference Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Callucci M (2001) Guidelines on urolithiasis. (Abbreviated version). Eur Urol 40:362–371PubMedCrossRef Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Callucci M (2001) Guidelines on urolithiasis. (Abbreviated version). Eur Urol 40:362–371PubMedCrossRef
15.
go back to reference Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36–41PubMedCrossRef Jendle-Bengten C, Tiselius HG (2000) Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Scand J Urol Nephrol 34:36–41PubMedCrossRef
16.
go back to reference Hess B, Mauron H, Ackermann D, Jaeger Ph (1999) Effects of a “common sense diet” on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 1999 36:136–143CrossRef Hess B, Mauron H, Ackermann D, Jaeger Ph (1999) Effects of a “common sense diet” on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 1999 36:136–143CrossRef
17.
go back to reference Pattras JG, Moore RG (1999) Citrate in the management of urolithiasis. J Endourol 13:687–691 Pattras JG, Moore RG (1999) Citrate in the management of urolithiasis. J Endourol 13:687–691
18.
go back to reference Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium–magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073PubMedCrossRef Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A (1997) Potassium–magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069–2073PubMedCrossRef
19.
go back to reference Lee YH, Huang WC, Tsai JY, Hung JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453–1457PubMedCrossRef Lee YH, Huang WC, Tsai JY, Hung JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453–1457PubMedCrossRef
20.
go back to reference Hofbauer J, Höbarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate nephrolithiasis—a prospective randomized study. Br J Urol 73:362–365PubMed Hofbauer J, Höbarth K, Szabo N, Marberger M (1994) Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate nephrolithiasis—a prospective randomized study. Br J Urol 73:362–365PubMed
21.
go back to reference Hess B, Hasler-Strub U, Ackermann D, Jaeger Ph (1997) Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 12:1362–1368PubMedCrossRef Hess B, Hasler-Strub U, Ackermann D, Jaeger Ph (1997) Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 12:1362–1368PubMedCrossRef
22.
go back to reference Höbarth K, Hofbauer J, Szabo N (1994) Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology 44:20–25PubMedCrossRef Höbarth K, Hofbauer J, Szabo N (1994) Value of repeated analyses of 24-hour urine in recurrent calcium urolithiasis. Urology 44:20–25PubMedCrossRef
23.
go back to reference Tiselius HG (1994) Investigation of single and recurrent stone formers. Miner Electrolyte Metab 20:321–327PubMed Tiselius HG (1994) Investigation of single and recurrent stone formers. Miner Electrolyte Metab 20:321–327PubMed
24.
go back to reference Bek-Jensen H, Tiselius HG (1998) Repeated urine analysis in patients with calcium stone disease. Eur Urol 33:323–332PubMedCrossRef Bek-Jensen H, Tiselius HG (1998) Repeated urine analysis in patients with calcium stone disease. Eur Urol 33:323–332PubMedCrossRef
25.
26.
go back to reference Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167:1607–1612PubMedCrossRef Parks JH, Goldfisher E, Asplin JR, Coe FL (2002) A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167:1607–1612PubMedCrossRef
27.
go back to reference Grampsas SA, Moore M, Chandhoke PS (2000) 10-year experience with extracorporeal shockwave lithotripsy in the state of Colorado. J Endourol 14:711–714PubMedCrossRef Grampsas SA, Moore M, Chandhoke PS (2000) 10-year experience with extracorporeal shockwave lithotripsy in the state of Colorado. J Endourol 14:711–714PubMedCrossRef
28.
go back to reference Laerum E (1984) Recurrent urolithiasis: a general-practice study of risk factors and clinical consequences. Scand J Urol Nephrol 18:67–70PubMed Laerum E (1984) Recurrent urolithiasis: a general-practice study of risk factors and clinical consequences. Scand J Urol Nephrol 18:67–70PubMed
29.
go back to reference Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthiazide reduces calcium oxalate calculus recurrences but magnesium hydroxide does not. J Urol 139:679–684PubMed Ettinger B, Citron JT, Livermore B, Dolman LI (1988) Chlorthiazide reduces calcium oxalate calculus recurrences but magnesium hydroxide does not. J Urol 139:679–684PubMed
30.
go back to reference Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H (1992) Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69:571–576PubMedCrossRef Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H (1992) Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69:571–576PubMedCrossRef
31.
go back to reference Borghi L, Meschi T, Guerra A, Novanni A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(suppl 6):78–86 Borghi L, Meschi T, Guerra A, Novanni A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(suppl 6):78–86
32.
go back to reference Ahlstrand C, Sandwall K, Tiselius HG (1996) Prophylactic treatment of calcium stone formers with hydrochlorothiazide and magnesium. In: Tiselius HG (eds) Renal stones—aspects on their formation, removal and prevention. Proceedings of the Sixth European Symposium on Urolithiasis 1995. Akademitryck AB, Edsbruk, pp 195–197 Ahlstrand C, Sandwall K, Tiselius HG (1996) Prophylactic treatment of calcium stone formers with hydrochlorothiazide and magnesium. In: Tiselius HG (eds) Renal stones—aspects on their formation, removal and prevention. Proceedings of the Sixth European Symposium on Urolithiasis 1995. Akademitryck AB, Edsbruk, pp 195–197
33.
go back to reference Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761–1764PubMed Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC (1993) Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761–1764PubMed
34.
go back to reference Tuncel A, Biri H, Küpeli B, Tan Ö, Sen I (2003) Efficiency of long-term potassium citrate treatment in patients with calcium oxalate stone disease. In: Sarica K, Kyagci F, Erbagci A, Inal Y (eds) Proceedings of the 2nd Eurolithiasis Society Meeting. Abstract. ReTa offset publishing, Gaziantep, p 273 Tuncel A, Biri H, Küpeli B, Tan Ö, Sen I (2003) Efficiency of long-term potassium citrate treatment in patients with calcium oxalate stone disease. In: Sarica K, Kyagci F, Erbagci A, Inal Y (eds) Proceedings of the 2nd Eurolithiasis Society Meeting. Abstract. ReTa offset publishing, Gaziantep, p 273
35.
go back to reference Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M, Knoll T (2006) Guidelines on Urolithiasis. European Association of Urology (EAU Guidelines office) Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M, Knoll T (2006) Guidelines on Urolithiasis. European Association of Urology (EAU Guidelines office)
Metadata
Title
Patients’ attitudes on how to deal with the risk of future stone recurrences
Author
Hans-Göran Tiselius
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 4/2006
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-006-0056-2

Other articles of this Issue 4/2006

Urolithiasis 4/2006 Go to the issue